These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 38191913)
1. Inhibition of PPP1R15A alleviates osteoporosis via suppressing RANKL-induced osteoclastogenesis. Ding ZB; Chen Y; Zheng YR; Wang YY; Deng WD; Zheng JH; Yang Q; Chen ZY; Li LH; Jiang H; Li XJ Acta Pharmacol Sin; 2024 Apr; 45(4):790-802. PubMed ID: 38191913 [TBL] [Abstract][Full Text] [Related]
2. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
3. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway. Li Y; Zhuang Q; Tao L; Zheng K; Chen S; Yang Y; Feng C; Wang Z; Shi H; Shi J; Fang Y; Xiao L; Geng D; Wang Z Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050 [TBL] [Abstract][Full Text] [Related]
4. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167 [TBL] [Abstract][Full Text] [Related]
5. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species. Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464 [TBL] [Abstract][Full Text] [Related]
6. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation. Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786 [TBL] [Abstract][Full Text] [Related]
7. (-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways. Hsiao HB; Wu JB; Lin WC BMC Complement Altern Med; 2017 May; 17(1):245. PubMed ID: 28468652 [TBL] [Abstract][Full Text] [Related]
8. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways. Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570 [TBL] [Abstract][Full Text] [Related]
9. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis. Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503 [TBL] [Abstract][Full Text] [Related]
10. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity. Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642 [TBL] [Abstract][Full Text] [Related]
11. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways. Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972 [TBL] [Abstract][Full Text] [Related]
12. Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis. Ye X; Jiang J; Yang J; Yan W; Jiang L; Chen Y Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1080-1089. PubMed ID: 35929595 [TBL] [Abstract][Full Text] [Related]
13. Zanthoxylum piperitum alleviates the bone loss in osteoporosis via inhibition of RANKL-induced c-fos/NFATc1/NF-κB pathway. Kim MH; Lee H; Ha IJ; Yang WM Phytomedicine; 2021 Jan; 80():153397. PubMed ID: 33130475 [TBL] [Abstract][Full Text] [Related]
14. Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorption. Li S; Teguh D; Wu D; Liu L; Hu C; Yuan J; Inderjeeth CA; Xu J J Cell Physiol; 2023 Aug; 238(8):1823-1835. PubMed ID: 37334837 [TBL] [Abstract][Full Text] [Related]
15. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis. Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192 [TBL] [Abstract][Full Text] [Related]
16. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways. Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053 [TBL] [Abstract][Full Text] [Related]
17. The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice. Zhao D; Wang Q; Zhao Y; Zhang H; Sha N; Tang D; Liu S; Lu S; Shi Q; Zhang Y; Dong Y; Wang Y; Shu B Menopause; 2018 Dec; 25(12):1459-1469. PubMed ID: 29944638 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca Cao B; Dai X; Wang W J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123 [TBL] [Abstract][Full Text] [Related]
19. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat. Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458 [TBL] [Abstract][Full Text] [Related]
20. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities. Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247 [No Abstract] [Full Text] [Related] [Next] [New Search]